Bullish Case: FDA approval of Anktiva has spurred optimism, potentially unlocking a new revenue stream and boosting market share in cancer treatments. This could lead to stronger investor confidence and continued upward momentum in IBRX's stock price.


Bearish Case: Despite recent FDA approval, high implied volatility signals market uncertainty and potential overvaluation. Ongoing financial strain and unresolved litigation could dampen the expected positive outcomes, leading to profit-taking or corrections.


Potential Outcomes:

1. Continued uptrend from Anktiva’s commercial success (40%).

2. Volatility spike from unresolved litigation (30%).

3. Potential financial strain prompting dilutive financing (20%).

4. Moderate market reaction adjusting from pre-approval hype (10%).


Trading Oracle: Sign Up to access trading oracle trade ideas.


April 24, 2024


ImmunityBio Forecast

IBRX        ImmunityBio
Price Forecast: BULLISH    Price Action: RANDOM (?)











Correlated Stock Forecasts

Assets that tend to move strongly with IBRX



WM Forecast + Options Trading Strategies   WM  Waste Management (0.91)


WING Forecast + Options Trading Strategies   WING  Wingstop (0.9)


BITO Forecast + Options Trading Strategies   BITO  ProShares Bitcoin Strategy (0.89)


GLD Forecast + Options Trading Strategies   GLD  SPDR Gold Shares (0.88)


TME Forecast + Options Trading Strategies   TME  Tencent Music Entertainment Group - (0.88)



Uncorrelated Stock Forecasts

Assets with little price relationship to IBRX



IGV Forecast + Options Trading Strategies   IGV  BlackRock Institutional Trust Company N.A. - iShares Expanded Tech-Software Sector (-0.0)


VRNT Forecast + Options Trading Strategies   VRNT  Verint Systems (-0.01)


BERY Forecast + Options Trading Strategies   BERY  Berry (0.01)


LTPZ Forecast + Options Trading Strategies   LTPZ  PIMCO 15+ Year U.S. TIPS Index Exchange-Traded (-0.01)


TUR Forecast + Options Trading Strategies   TUR  BlackRock Institutional Trust Company N.A. - iShares MSCI Turkey (-0.01)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against IBRX



NBR Forecast + Options Trading Strategies   NBR  Nabors Industries (-0.8)


GLL Forecast + Options Trading Strategies   GLL  ProShares UltraShort Gold (-0.8)


AEHR Forecast + Options Trading Strategies   AEHR  Aehr Test Systems (-0.81)


EXTR Forecast + Options Trading Strategies   EXTR  Extreme Networks (-0.82)


ATSG Forecast + Options Trading Strategies   ATSG  Air Transport Services (-0.87)





Become a more profitable investor with AI optimized trading strategies






×

Chat with IBRX


 Ask any question about IBRX!